Sustainability has become one of the most important business priorities for pharmaceutical companies seeking to meet regulatory requirements and environmental goals. Although the pharmaceutical industry is not usually associated with pollution and waste, there is no denying the environmental and operational footprint created by its complex global supply chains. As stakeholders, communities, and investors raise their expectations for transparency and accountability, organizations are under more pressure than ever to demonstrate their commitment to sustainable and responsible business practices. For companies that want to gain stakeholder trust and build a long-term strategy around sustainability, ESG (Environmental, Social, and Governance) is no longer just a “nice-to-have”; it is now a strategic asset.